Genentech Articles
CLINTON VICTORY GOOD FOR SOME PHARMA COS
9 November 1992
NEW BIOTECH R&D UNIT FOR GENENTECH
2 November 1992
US AIDS VACCINE TRIAL SPARKS BITTER DISPUTE
2 November 1992
Earningstable
26 October 1992
ROCHE'S ADR OFFER WELL RECEIVED
12 October 1992
GENENTECH, UNIVAX LINK FOR AIDS R&D
5 October 1992
NORTH AMERICAN NEWS IN BRIEF
7 September 1992
TOYOBO CALLS HALT TO t-PA SALES
6 July 1992
SCHERING FILES SUIT AGAINST GENENTECH
6 July 1992
WORLD PRODUCT NEWS IN BRIEF
15 June 1992
GENENTECH'S HUMAN HER-2 ENTERS PHASE I
1 June 1992
1991 A SATISFYING YEAR FOR ROCHE
18 May 1992
ROCHE'S STRONG 1st QTR GOOD FOR 1992
11 May 1992
GENENTECH'S EXPANDING PRODUCT PORTFOLIO
11 May 1992
GENENTECH'S DNase EFFECTIVE IN CF
11 May 1992
BTG'S rhGH APPROVED IN FRANCE
27 April 1992
STOCK MARKET COMMENTARY: TOKYO
27 April 1992
IMPROVEMENTS IN 1ST QTR FOR US FIRMS
20 April 1992
GENENTECH REBUFFS ISIS-3 AND AWAITS GUSTO
6 April 1992
GENENTECH REBUFFS ISIS-3 AND AWAITS GUSTO
6 April 1992
GENENTECH'S DNase IN CYSTIC FIBROSIS
23 March 1992
STOCK MARKET COMMENTARY: NEW YORK
16 March 1992
EFPIA CHALLENGES EC DRAFT ON DRUG PRICING
16 March 1992
ROCHE TO PROMOTE GENENTECH'S DNase
9 March 1992
B-M SQUIBB GIVES HEART DRUGS FREE TO POOR
3 February 1992
ALZHEIMER'S DISEASE: US CONCERN
27 January 1992
1991 A YEAR OF STRONG GROWTH IN THE USA
27 January 1992
GENENTECH TO START TRIALS OF HER-2
27 January 1992
STOCK MARKET COMMENTARY: NEW YORK
13 January 1992
CELTRIX TO BECOME MAJOR BIOTECH PLAYER
13 January 1992
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
